MVP 3.37% 43.0¢ medical developments international limited

Ann: Annual Report to shareholders-MVP.AX, page-9

ANNOUNCEMENT SPONSORED BY PLUS500
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM
CFD Service. Your Capital is at risk
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
  1. 1,953 Posts.
    lightbulb Created with Sketch. 187
    Seriously?
    ALL analgesics run the risk of addiction, including an over reliance of inhaled pain relief. There are inherent dangers with any pain relieving medication that is readily available. Oh, and refresh my memory, why were the FDA reticent about its US distribution? The addiction of 'safe' analgesics are increasingly problematic. You suggest "a better solution for medical professionals", but in the hands of unsupervised 'mere mortals', you're inviting trouble, non-narcotic or not, in my humble opinion. I would question the use of the term 'non addictive', if it's freely available and in every home, how many peole do you think will use it for minimal ailments? Abuse its intended purpose?
 
watchlist Created with Sketch. Add MVP (ASX) to my watchlist
(20min delay)
Last
43.0¢
Change
-0.015(3.37%)
Mkt cap ! $48.44M
Open High Low Value Volume
45.0¢ 45.0¢ 43.0¢ $81.49K 185.7K

Buyers (Bids)

No. Vol. Price($)
2 19123 43.0¢
 

Sellers (Offers)

Price($) Vol. No.
44.0¢ 6232 1
View Market Depth
Last trade - 15.58pm 18/10/2024 (20 minute delay) ?
MVP (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.